Original article| Volume 10, ISSUE 4, P206-208, December 1999

Free radical activity and antioxidative systems in patients with systemic sclerosis


      Background: Free radicals have been said to contribute to vascular damage in patients with systemic sclerosis. The aim of the study was to determine the level of lipid peroxidation products and antioxidative enzyme activity in patients with systemic sclerosis and in healthy controls. Methods: 10 women with definite systemic sclerosis and 10 age-matched healthy women were studied. Results: A significant increase in serum lipid peroxidation product levels (i.e. diene conjugates and thiobarbituric acid-reactive substances) was found in patients with systemic sclerosis. These changes were accompanied by a decrease in superoxide dismutase, catalase, and glutathione peroxidase activity in erythrocyte lysate. Furthermore, there was diminished activity of glutathione reductase and a depressed total serum level of antioxidants compared to the controls. Blood thiol group concentration in patients with systemic sclerosis was also found to be decreased. Conclusions: The results obtained indicate increased oxidative stress in patients with systemic sclerosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore: Williams and Wilkins, 1996.

        • Kahaleh MB
        Vascular disease in scleroderma.
        Rheum Dis Clin N Am. 1990; 16: 53-73
        • Yamane K
        • Miyauchi T
        • Suzuki N
        • Yahara T
        • Akama T
        • Suzuki H
        • Kashiwagi H
        Significance of plasma endothelin-1 levels in patients with systemic sclerosis.
        J Rheumatol. 1992; 19: 1566-1571
        • Vascheeswaran R
        • Magoulas T
        • Efrat G
        • Penny RM
        • Black CM
        Circulating endothelin-1 levels in systemic sclerosis subsets: a marker of fibrosis or vascular dysfunction?.
        J Rheumatol. 1994; 21: 1838-1844
        • Korn JH
        Immunological aspects of scleroderma.
        Curr Opin Rheumatol. 1991; 3: 278-288
        • Kucharz EJ
        • Zarzycka-Machnik A
        • Wadas U
        • Kotulska A
        • Bogdanowski T
        • Brzecińska-Wcisło L
        • Tobor Z
        • Hamouda H
        Serum level of soluble intercellular adhesion molecule-1 in patients with systemic sclerosis.
        Eur J Intern Med. 1998; 8: 123-125
        • Murrel DF
        A radical proposal for the pathogenesis of scleroderma.
        J Am Acad Dermatol. 1993; 28: 78-85
        • Bruckdorfer KR
        • Hillary JB
        • Bunee T
        • Vancheeswaran R
        • Block CM
        Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis.
        Arthritis Rheum. 1995; 38: 1060-1076
        • Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostics and Therapeutic Criteria Committee
        Preliminary criteria for the classification of systemic sclerosis.
        Arthritis Rheum. 1980; 23: 581-590
        • Lunec J
        • Dormandy TL
        Fluorescent lipid-peroxidation products in synovial fluid.
        Clin Sci. 1979; 56: 53-59
      2. Yagi K. Assay for blood plasma or serum. Methods in enzymology, vol. 105. New York: Academic Press, 1984:328–331.

      3. Aebi M. Catalase. Methods for determination of enzyme. In: Bergmayer HV, editor. Methods of enzymatic analysis, vol. 2. New York: Academic Press, 1974:673–684.

        • Ellman G
        Tissue sulfhydryl groups.
        Arch Biochem Biophys. 1959; 82: 70-77
        • Kelly F
        Use of antioxidants in the prevention and treatment of disease.
        J Intern Fed Clin Chem Lab Med. 1998; 10: 21-23
        • Lunec J
        • Winyard P
        Reactive oxygen species: associated pathology.
        J Intern Fed Clin Chem Lab Med. 1998; 10: 42-44